Overview

The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Status:
Completed
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
This phase II trial attempts to evaluate the efficacy and safety of Jincaopian Tablets in the treatment of subjects with chronic pelvic pain after pelvic inflammatory disease.
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Konruns Pharmaceutical Co., Ltd.